P3‐281: The safety profile of ACI‐24, an oligo‐specific amyloid beta vaccine, demonstrated decrease of large microbleedings in brain of aged Alzheimer's disease mouse model

Maria Pihlgren(World Trade Organization), Katarzyna Stanco‐Piorko(AC Immune (Switzerland)), Rime Madani(AC Immune (Switzerland)), Andrea Pfeifer(AC Immune (Switzerland)), David T. Hickman(AC Immune (Switzerland)), Fred Van Leuven(KU Leuven), Andreas Muhs(AC Immune (Switzerland)), Valérie Giriens(AC Immune (Switzerland)), Ingrid Van der Auwera(University of Illinois Chicago), Nathalie Chuard(AC Immune (Switzerland))
Alzheimer s & Dementia
June 25, 2009
10.1016/j.jalz.2009.04.952
Cited by 3

Related Papers

Early Phenotypic Changes in Transgenic Mice That Overexpress Different Mutants of Amyloid Precursor Protein in Brain
|Journal of Biological Chemistry|1999|668
A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model
|Journal of Clinical Investigation|2004|622
Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1–42 levels in APPV717I transgenic mice
|Brain|2005|562
Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency
|Proceedings of the National Academy of Sciences|1999|523
Structural and Functional Characterization of Nrf2 Degradation by the Glycogen Synthase Kinase 3/β-TrCP Axis
|Molecular and Cellular Biology|2012|473